Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
New Century Healthcare Holdings Co (HKSE:01518) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
New Century Healthcare Holdings Co EBITDA Margin % Related Terms
New Century Healthcare Holdings Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Century Healthcare Holdings Co EBITDA Margin % Chart
HKSE:01518 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, New Century Healthcare Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Century Healthcare Holdings Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, New Century Healthcare Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where New Century Healthcare Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Century Healthcare Holdings Co (HKSE:01518) has a EBITDA Margin % of -10.32% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on New Century Healthcare Holdings Co and its competitors. According to the industry distribution chart, New Century Healthcare Holdings Co ranks #550 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 82.8%.
Is New Century Healthcare Holdings Co's EBITDA Margin % too high?
New Century Healthcare Holdings Co's current EBITDA Margin % is -10.32%. Based on the distribution chart, New Century Healthcare Holdings Co ranks #550 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, New Century Healthcare Holdings Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does New Century Healthcare Holdings Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, New Century Healthcare Holdings Co ranks #550 out of 664 companies for EBITDA Margin %. This places New Century Healthcare Holdings Co in the lower half of its industry. The industry median EBITDA Margin % is 10.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on New Century Healthcare Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Century Healthcare Holdings Co's current EBITDA Margin % is -10.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Century Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, New Century Healthcare Holdings Co (HKSE:01518) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.57, compared to a current price of HK$0.24 — trading 57.9% below its estimated fair value. The current EBITDA Margin % is -10.32%. New Century Healthcare Holdings Co's overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For New Century Healthcare Holdings Co (HKSE:01518), the current EBITDA Margin % is -10.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Century Healthcare Holdings Co (HKSE:01518) Overvalued in 2026?
Based on GuruFocus' analysis, New Century Healthcare Holdings Co stock appears to be undervalued.
The current stock price of HK$0.24 is trading 57.9% below its estimated GF Value™ of HK$0.57.
GuruFocus considers New Century Healthcare Holdings Co to be Possible Value Trap.
Key valuation signals for HKSE:01518:
EBITDA Margin %: -10.32%
GF Value™: HK$0.57 vs. price of HK$0.24 (57.9% below fair value)
No single metric tells the full story. See the HKSE:01518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Century Healthcare Holdings Co Ltd is an investment holding company engaged in the healthcare industry. The company specializes in the provision of medical services to women and childre. The segments of the company include Pediatric services, Obstetrics services, Gynecology services, and Others. The group's revenue is mostly derived from activities in the PRC. A majority of income is generated from the Pediatrics segment.
41GF Score
Get the complete analysis for HKSE:01518
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01518 has been successfully added to your 
